In the United States, cancer ranks as the second most common cause of death. Clinical trials convert discoveries made in basic science into cancer treatments that patients require. One of the major obstacles to the conclusion of oncology clinical trials is the inadequate accrual of study participants. This study sought to fill knowledge gaps and provide areas for future research by looking into trial-level variables that influence the enrollment and/or completion of oncology clinical trials.
